Analyst Research

Report Title Price
Provider : Thomson Reuters Stock Report
Provider : Reuters Investment Profile
Provider : Wright Reports
Provider : Thomson Reuters Stock Report

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Samsung Pharm Ind announces change of CEO

Monday, 7 Jul 2014 03:31am EDT 

Samsung Pharm Ind Co Ltd:Appoints Lee Yik Wu as chief executive officer of the company, to replace Kim Won Gyu, effective July 7. 

Company Quote

-100.0 -0.78%
6 Oct 2015